Clinical Trial Update: PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study) [Phase 3]

View source ↗

Summary

Phase 3 trial update on PGL4001 evaluating reduction of symptoms in uterine fibroids (PEARLIII-extension); the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• PGL4001

Snippet

Sponsor: PregLem SA | Conditions: Uterine Fibroids | Phase 3 | Status: COMPLETED